Drug Discovery World

APRIL 14, 2023

He is being recognised for his fundamental discoveries dedicated to characterising the genetic drivers of human B-cell lymphomas and for uncovering new avenues for cancer prevention and therapy that have been routinely exploited clinically to diagnose and determine novel therapeutic strategies for B-cell lymphoma.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

Drug Discovery World

NOVEMBER 13, 2023

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.

Engineering 147

Engineering Science Bioinformatics Vaccine 147

Drug Discovery World

NOVEMBER 8, 2023

Presentations include: Marjolein van Egmond, PhD, Professor, Oncology and Inflammation, Surgery/Molecular Cell Biology and Immunology, Amsterdam UMC, on: ‘Novel FcαRI bispecific antibody immunocytokines for the recruitment of myeloid effector cells in cancer therapy’.

Engineering 162

Engineering Protein Expression Therapies Science 162

Codon

APRIL 16, 2023

This looks like an early step toward a much different future for biology: One in which natural language is used to design experiments, program robots, and automate experiments in high-throughput. Skin microbes can trigger strong immune responses. epidermidis , can actually trigger tumor-specific T cells. McCafferty C.L.

Engineering 52

Engineering DNA RNA Science 52